UY23606A1 - PROCEDURE FOR THE PREPARATION OF HYDROXAMIC ACID DERIVATIVES.- - Google Patents

PROCEDURE FOR THE PREPARATION OF HYDROXAMIC ACID DERIVATIVES.-

Info

Publication number
UY23606A1
UY23606A1 UY23606A UY23606A UY23606A1 UY 23606 A1 UY23606 A1 UY 23606A1 UY 23606 A UY23606 A UY 23606A UY 23606 A UY23606 A UY 23606A UY 23606 A1 UY23606 A1 UY 23606A1
Authority
UY
Uruguay
Prior art keywords
atom
preparation
bonding
procedure
het
Prior art date
Application number
UY23606A
Other languages
Spanish (es)
Inventor
Michael John Broadhurst
Paul Anthony Brown
William Henry Johnson
Geoffrey Lawton
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY23606A1 publication Critical patent/UY23606A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/22—Hydroxylamino compounds or their ethers or esters having oxygen atoms of hydroxylamino groups esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C07K5/06043—Leu-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un procedimiento para la preparación de compuestos de fórmula general (I) (figura 1) en donde R2 representa, entre otras posibilidades, un grupo de la fórmula -(CH2)n-Het en donde n tiene un valor de 1-4 y Het representa un anillo N-heterocíclico pentagonal o hexagonal que (a) está unido vía el átomo de N, (b) contiene opcionalmente N, O y/o S como heteroátomo(s) adicional(es) en una posición o posiciones distintas de adyacente(s) al átomo de N de enlace, (c) está sustituido por oxo o uno o ámbos átomos de C adyacentes al átomo de N de enlace y (d) está opcionalmente benzo-fusionado u opcionalmente sustituido en uno o más de otros átomos de carbono por alquilo de 1-6C; y sus sales famraceuticamente aceptables. Como ejemplo no limitante: etilamida de [4-(N-hidroxiamino)-2(R o S)-heptilsuccinil]-L-leucina. El medicamento es útil para el control o prevención de enfermedades de las articulaciones degenerativas o en el tratamiento de tumores invasivos, ateroesclerosis o esclerosis múltiple.The present invention refers to a process for the preparation of compounds of general formula (I) (figure 1) in which R2 represents, among other possibilities, a group of the formula - (CH2) n-Het in which n has a value of 1-4 and Het represents a pentagonal or hexagonal N-heterocyclic ring which (a) is attached via the N atom, (b) optionally contains N, O and / or S as additional heteroatom (s) in a position (s) other than adjacent to the bonding N atom, (c) is substituted by oxo or one or both of the C atoms adjacent to the bonding N atom and (d) is optionally benzo-fused or optionally substituted at one or more other carbon atoms per 1-6C alkyl; and its pharmaceutically acceptable salts. As a non-limiting example: [4- (N-hydroxyamino) -2 (R or S) -heptylsuccinyl] -L-leucine ethylamide. The drug is useful for the control or prevention of degenerative joint diseases or in the treatment of invasive tumors, atherosclerosis or multiple sclerosis.

UY23606A 1992-06-25 1993-06-24 PROCEDURE FOR THE PREPARATION OF HYDROXAMIC ACID DERIVATIVES.- UY23606A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929213473A GB9213473D0 (en) 1992-06-25 1992-06-25 Hydroxamic acid derivatives

Publications (1)

Publication Number Publication Date
UY23606A1 true UY23606A1 (en) 1993-12-15

Family

ID=10717706

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23606A UY23606A1 (en) 1992-06-25 1993-06-24 PROCEDURE FOR THE PREPARATION OF HYDROXAMIC ACID DERIVATIVES.-

Country Status (12)

Country Link
KR (1) KR100311556B1 (en)
BR (1) BR9302642A (en)
GB (2) GB9213473D0 (en)
HR (1) HRP930980A2 (en)
MX (1) MX9303672A (en)
MY (1) MY134743A (en)
PL (1) PL299465A1 (en)
SI (1) SI9300313A (en)
TW (1) TW279157B (en)
UY (1) UY23606A1 (en)
YU (1) YU40293A (en)
ZA (1) ZA934398B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601368D0 (en) * 1986-01-21 1986-02-26 Ici America Inc Hydroxamic acids
US5189178A (en) * 1990-11-21 1993-02-23 Galardy Richard E Matrix metalloprotease inhibitors

Also Published As

Publication number Publication date
ZA934398B (en) 1993-12-27
KR940005556A (en) 1994-03-21
YU40293A (en) 1997-07-31
TW279157B (en) 1996-06-21
KR100311556B1 (en) 2002-02-19
MX9303672A (en) 1994-01-31
GB9213473D0 (en) 1992-08-12
GB9307081D0 (en) 1993-05-26
SI9300313A (en) 1993-12-31
MY134743A (en) 2007-12-31
HRP930980A2 (en) 1997-02-28
PL299465A1 (en) 1994-03-07
BR9302642A (en) 1994-01-11

Similar Documents

Publication Publication Date Title
AR016817A1 (en) DERIVATIVES OF FENILUREA OR FENILTIOUREA, PROCEDURE FOR PREPARATION, COLLECTION OF COMPOUNDS, INTERMEDIARY COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
PA8431301A1 (en) METALOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AND USEFUL METHODS AND INTERMEDIATES FOR THEIR PREPARATION
FR2662162B1 (en) NOVEL DERIVATIVES OF AMINO PIPERIDINE, AMINO PYRROLIDINE AND AMINO PERHYDROAZEPINE, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
KR950017957A (en) Preparation and intermediates of 3, 4, 4-trisubstituted-piperidinyl-N-alkylcarboxylates
ATE228115T1 (en) BCYCLIC FIBRINOGEN ANTAGONISTS
MX9203744A (en) WATER-Soluble CAMPTOTECHE ANALOGS USEFUL TO INHIBIT THE GROWTH OF ANIMAL TUMOR CELLS.
KR890011592A (en) Composition for the treatment of endotracheal ischemia
DK0427247T3 (en) Drug containing R-alpha-lipoic acid or S-alphalipoic acid as active ingredient
EA200500088A1 (en) TRICYCLIC MODULATORS OF NUCLEAR RECEPTOR STEROID HORMONE
AR042368A1 (en) A COMPOUND DERIVED FROM PURINA, ITS USE, A PROCEDURE TO PREPARE IT AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
LU90956I2 (en) Metvix active ingredient methylaminolevulinic in the form of a salt preferably methylaminolevulinic hydrochloride
NO160076C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZOCSAZOL AND BENZOTIANOLAMIN DERIVATIVES.
ES2202322T3 (en) USE OF THIAZOLIDINADIONS FOR THE TREATMENT OF ATEROSCLEROSIS AND FOOD DISORDERS.
AR013079A1 (en) SUBSTITUTED DERIVATIVES OF TETRAHIDROFURANO-3-ONAS, TETRAHIDROPIRANO-3- ONAS AND TETRAHIDROTIOFEN-3-ONAS, A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION OF A MEDICINAL PRODUCT USEFUL AS INTERMEDIATE PROTEIN INHIBITORS
JP2009541484A (en) A combination comprising a 5HT6 modulator and a cholinesterase inhibitor
DK491489D0 (en) IMIDAZOLINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
NO943895L (en) Galantamine derivatives, a method of preparation and their use as medicaments
AR018576A1 (en) USE OF AN N- [RENT (OR ARIL) SULFONIL] -L, L-DIPEPTIDAL COMPOUND FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION, SUCH PHARMACEUTICAL COMPOSITION AND COMMERCIAL PRODUCT THAT INCLUDES IT
MX9202146A (en) DERIVATIVES OF AMINO ACID, PROCEDURE FOR ITS PREPARATION AND MEDICATION THAT CONTAIN THEM.
AR032598A1 (en) OXAZINQUINOLONES, A PHARMACEUTICAL COMPOSITION AND THE USE OF THE SAME TO PREPARE A USEFUL MEDICINAL PRODUCT IN THE TREATMENT OF VIRAL INFECTIONS
UY23606A1 (en) PROCEDURE FOR THE PREPARATION OF HYDROXAMIC ACID DERIVATIVES.-
KR100759771B1 (en) Agent for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient
FR2681864B1 (en) NOVEL BICYCLIC NITROGEN DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
NO913023L (en) NEW BICYCLIC AMINOSUBSTITUTED COMPOUNDS
KR950702544A (en) Biphenylmethane Derivatives and Pharmaceuticals Containing the Same